Continuous positive airway pressure (CPAP) therapy and high-flow oxygen therapy (HFOT) are two types of treatment that provide effective respiratory support to hospital patients. These non-invasive therapies help ensure proper airway functions for those who are suffering from acute respiratory failure and other respiratory emergencies, especially amid the COVID-19 pandemic wherein non-invasive ventilation has become a crucial component of patient care.
One problem encountered by most hospitals today is the need to maintain different systems just to be able offer both CPAP and HFOT treatments to patients. This will require purchasing different devices resulting in increased operational costs. For patients who need both treatments, transitioning from HFOT to CPAP can also be very inconvenient, and even a few seconds of not getting respiratory support can become fatal.
To help Philippine hospitals address these problems, HealthSolutions, the country’s leading marketer and distributor of medical equipment and supplies, and Armstrong Medical have launched in the country the AquaVENT FD140i, a dual therapy flow driver that offers both CPAP and HFOT in a single device. The virtual launch took place last March 10 over Zoom.
The most notable feature of the AquaVENT FD140i is its ability to deliver CPAP and HFOT in just one compact device. It allows seamless transitions between the two therapies, improving the quality of care for patients. It can also be used by different departments in the hospital, thus, reducing overall costs.
Additionally, the AquaVENT FD140i has multiple innovative features that make it easier for healthcare professionals to manage their patients’ respiratory needs. It has a therapy timer that assists with early assessment, a respiratory rate indicator, alarms for pressure and apnea, and an indicator that highlights patients’ work of breathing and helps with setting optimal flow rates, all accessible through an optimized touch-screen monitor.
Aside from the virtual launch of AquaVENT FD140i, a discussion on CPAP and HFOT was also led by Dr. Parjam Zolfaghari, a consultant in Intensive Care Medicine and Anaesthesia for Barts Health NHS Trust in London. In his presentation, Dr. Zolfaghari talked about the pros and cons of both CPAP and HFOT, including when it is best to use each treatment. He was joined by Armstrong Medical’s Sales and Marketing Director Nigel Armstrong and Armstrong Medical’s product educator David McCready, who both talked about the HFOT and CPAP capabilities of the AquaVENT FD140i.
The AquaVENT FD140i by Armstrong Medical is exclusively distributed in the Philippines by HealthSolutions. To learn more about this and other products offered by HealthSolutions, visit the official website at http://healthsolutions.com.ph/.